Do France, Germany, and Italy agree on the added therapeutic value of medicines?
Giorgio CasilliDario LidonniciClaudio JommiMarika De NigrisArmando A GenazzaniPublished in: International journal of technology assessment in health care (2023)
A high degree of concordance between HTA organizations is reached when considering jointly ATV and quality of evidence, suggesting that the system is extensively mature to make a Joint Clinical Assessment, avoiding duplications and reducing access inequalities.
Keyphrases